Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04603495
Title Study of CPI-0610 in Myelofibrosis (MF) (MANIFEST-2)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Constellation Pharmaceuticals
Indications

myelofibrosis

Therapies

CPI-0610 + Ruxolitinib

Ruxolitinib

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | CAN | BEL | AUT


No variant requirements are available.